Shots: The P-III ADAURA study involves assessing of Tagrisso (80 mg, qd) vs PBO in the adjuvant treatment of 682 patients with stage IB, II, and IIIA EGFRm NSCLC with complete tumor resection & adjuvant CT as an option across 20+ countries Results: in 1EPs of DFS & DFS in IIT population (83% & 79%) […]Read More
